ArticlePloS one2013

A kinome screen identifies checkpoint kinase 1 (CHK1) as a sensitizer for RRM1-dependent gemcitabine efficacy.

Jun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.